Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1

Cellular Physiology and Biochemistry

Volumn 33, Issue 6, 2014, Pages 1863-1875

  Ao, Ning ^a   Liu, Yanyan ^a   Feng, Hailiang ^a   Bian, Xiaocui ^a   Li, Zhanwen ^a   Gu, Bei ^a   Zhao, Xiaomei ^a   Liu, Yuqin ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Acetylation; Deubiquitinating; SIRT1; STAT3; USP22

Indexed keywords

DEUBIQUITINASE; GELATINASE B; MESSENGER RNA; SIRTUIN 1; SMALL INTERFERING RNA; STAT PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR TWIST; UBIQUITIN SPECIFIC PEPTIDASE 22; UNCLASSIFIED DRUG; PROTEIN BINDING; SIRT1 PROTEIN, HUMAN; THIOL ESTER HYDROLASE; USP22 PROTEIN, HUMAN; PEPTIDASE; UBIQUITIN;

ACETYLATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER CELL LINE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; WESTERN BLOTTING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HT 29 CELL LINE; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; DEUBIQUITINATION; GENE EXPRESSION; IMMUNOPRECIPITATION; PLASMID; PROTEIN ACETYLATION; PROTEIN MODIFICATION;

ACETYLATION; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HEK293 CELLS; HT29 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SIRTUIN 1; STAT3 TRANSCRIPTION FACTOR; THIOLESTER HYDROLASES; UBIQUITINATION;

EID: 84902905730     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362964     Document Type: Article

References (24)

1. Zhang XY, Pfeiffer HK, Thorne AW, McMahon SB: USP22, An hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle 2008;7:1522-1524.
2. Lang G, Bonnet J, Umlauf D, Karmodiya K, Koffler J, Stierle M, Devys D, Tora L: The tightly controlled deubiquitination activity of the human SAGA complex differentially modifiesdistinct gene regulatory elements. Mol Cell Biol 2011;31:3734-3744.
3. Atanassov BS, Dent SY: USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. Embo Reports 2011;12:924-930.
4. Atanassov BS1, Evrard YA, Multani AS, Zhang Z, Tora L, Devys D, Chang S, Dent SY: Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance. Mol Cell 2009;35:352-364.
5. Lin Z, Yang H, Kong Q, Li J, Lee SM, Gao B, Dong H, Wei J, Song J, Zhang DD, Fang D: USP22 antagonizes p53 transcriptional activation by deubiquitinating SIRT1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell 2012;46:484-494.
6. Armour SM, Bennett EJ, Braun CR, Zhang XY, McMahon SB, Gygi SP, Harper JW, Sinclair DA: A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex. Mol Cell Biol 2013;33:1487-1502.
7. Smith JS, Brachmann CB, Celic I, Kenna MA, Muhammad S, Starai VJ, Avalos JL, Escalante-Semerena JC, Grubmeyer C, Wolberger C, Boeke JD: A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sei 2000;97:6658-6663.
8. Luo K, Vega-Palas MA, Grunstein M: Rapl-Sir4 binding independent of other Sir, yKu, or histone interactions initiates the assembly of telomeric heterochromatin in yeast. Genes Dev 2002;16:1528-1539.
9. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T: Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002;21:2383-2396.
10. Yuan J, Minter-Dykhouse K, Lou Z: A c-Myc-SIRTl feedback loop regulates cell growth and transformation. ] Cell Biol 2009;185:203-211.
11. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L: Mammalian SIRT1 represses forkhead transcription factors. Cell 2004;116:551-563.
12. Zhang J, Lee SM, Shannon S, Gao B, Chen W, Chen A, Divekar R, McBurney MW, Braley-Mullen H, Zaghouani H, Fang D: The type III histone deacetylase SIRT1 is essential for maintenance of T cell tolerance in mice. ] Clin Invest 2009;119:3048-3058.
13. Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A, Girolomoni G, Albanesi C: STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a directinhibition of STAT3 acetylation. FASEB J 2011;25:916-927.
14. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
15. Zhong Z, Wen Z, Darnell JE Jr: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95-98.
16. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB: Stat3 regulates genes common to both wound healing and cancer. Oncogene 2005;24:3397-3408.
17. Yuan ZL, Guan YJ, Chatterjee D, Chin YE: Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005;307:269-273.
18. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman G I, Horvath TL, Gao Q: STAT3 inhibition of gluconeogenesis is downregulated by SIRT Nat Cell Biol 2009;11:492-450.
19. Alvarez JV, Frank DA: Genome-wide analysis of STAT3 target genes: elucidating the mechanism of STAT-mediated oncogenesis. Cancer Biol Ther 2004;3:1045-1050.
20. Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M, Xu LM, Costanzo C, Cheng JQ, Wang LH: Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 2008;283:14665-14673.
21. Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL, McMahon SB:. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required ft activated transcription and cell-cycle progression. Mol Cell 2008;29:102-111.
22. Chipumuro E, Henriksen MA.The ubiquitin hydrolase USP22 contributes to 3-end processing of JAK-inducible genes. FASEB J 2012;26:842-854.
23. Li ZW, Liu YQ: Progress of targeted therapy related to K-ras mutation. Zhong Hua Bing Li Xue Za Zhi 2012;41:59-61.
24. Ohbayashi N, Ikeda 0, Taira N, Yamamoto Y, Muromoto R, Sekine Y, Sugiyama K, Honjoh T, Matsuda T: LIF-And IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation. Biol Pharm Bull 2007;30:1860-1864.